Vitiligo is a chronic skin condition in which the immune system destroys the cells that produce pigment, leaving smooth white patches on the skin. It affects roughly 0.4% of the global population, with a higher prevalence in adults (0.7%) than in children and adolescents (0.27%). The condition is not contagious, not painful, and not dangerous on its own, but it can have a significant emotional and psychological impact.
What Causes Vitiligo
Your skin gets its color from cells called melanocytes. In vitiligo, the immune system mistakenly identifies these cells as threats and destroys them. The key attackers are a type of white blood cell called CD8+ T cells, which kill melanocytes directly by puncturing their membranes or triggering a self-destruct signal. These immune cells also release a chemical messenger called interferon-gamma, which recruits even more immune cells to the area and amplifies the attack.
What makes vitiligo particularly stubborn is a second layer of immune activity. Once the initial damage happens, the body stations “memory” immune cells in the skin. These memory cells act like sentries, ready to reactivate the inflammatory cycle if they detect pigment-producing cells trying to recover. This is why vitiligo patches tend to persist and why repigmented skin can lose color again.
The initial trigger for this immune misfire varies. Genetics play a clear role: certain immune-system genes increase susceptibility, with one variant raising the odds by about 50%. But genes alone don’t cause vitiligo. Physical stress to the skin, including friction, burns, cuts, sunburn, and even chronic pressure from tight clothing, can provoke new patches through what’s known as the Koebner phenomenon. Emotional stress and chemical exposure to certain industrial compounds have also been linked to flare-ups.
What Vitiligo Looks Like
The hallmark sign is milky-white patches with well-defined borders on otherwise normal skin. These patches are completely flat; the skin texture itself doesn’t change. On lighter skin tones, the contrast may be subtle until the surrounding skin tans in the sun. On darker skin tones, patches are more immediately visible. Common early sites include the hands, face, feet, and areas around body openings like the eyes, nostrils, and navel.
Hair growing within a vitiligo patch often turns white as well, since melanocytes in hair follicles are also affected. This is called poliosis and can appear in eyebrows, eyelashes, or scalp hair.
Two Main Types
Vitiligo falls into two broad categories that behave quite differently.
Non-segmental vitiligo is by far the more common type, accounting for about 78% of cases. It tends to appear symmetrically on both sides of the body and is prone to spreading over time. Even after long periods of stability, reactivation occurs in 80 to 100% of non-segmental cases. The most common subtype is acrofacial, meaning patches concentrate on the face, hands, and feet.
Segmental vitiligo makes up about 16.5% of cases. It typically affects one area on one side of the body, spreads rapidly at first, then stabilizes. Once it has been inactive for two years, the chance of reactivation drops significantly. Over the course of the disease, people with segmental vitiligo spend roughly 71% of their time in a stable phase, compared to only about 54% for non-segmental vitiligo.
How It’s Diagnosed
A dermatologist can usually identify vitiligo by examining the skin visually. The most helpful diagnostic tool is a Wood’s lamp, a handheld ultraviolet light used in a darkened room. Under this light, vitiligo patches glow a bright blue-white, making them easy to distinguish from other causes of lighter skin like eczema, fungal infections, or post-inflammatory lightening. The lamp also reveals patches that aren’t yet visible to the naked eye, which helps map the full extent of the condition.
Blood tests aren’t needed to diagnose vitiligo itself, but your doctor will often check thyroid function. About 14.3% of people with vitiligo also develop autoimmune thyroid disease, and roughly 21% test positive for thyroid-related antibodies even before symptoms appear. Catching thyroid problems early matters because they’re easily treatable once identified.
Treatment Options
Topical Treatments
For limited areas of vitiligo, creams applied directly to the skin are the first-line approach. Corticosteroid creams can slow the immune attack and sometimes prompt repigmentation in small patches. A newer option is ruxolitinib cream, the first treatment specifically approved for vitiligo repigmentation. In clinical trials, about 50% of patients using it twice daily achieved at least 75% facial repigmentation within a year. Results were consistent regardless of how long someone had vitiligo or whether the disease was currently active or stable.
Light Therapy
Narrowband UVB phototherapy is the most widely used treatment for widespread vitiligo. It works by stimulating any remaining melanocytes to produce pigment and migrate into the white patches. Sessions typically happen two to three times per week, and the standard treatment course runs 9 to 12 months to reach approximately 40 to 50% repigmentation. Results are gradual; small dots of pigment appear around hair follicles within the patches and slowly expand and merge. Face and neck patches tend to respond best, while hands and feet are the most resistant.
Surgical Approaches
When vitiligo has been stable for at least one year, with no new patches, no expansion of existing ones, and no Koebner response to skin injury, surgical options become available. The most common procedure involves harvesting a thin layer of the patient’s own pigmented skin, separating the melanocytes, and transplanting them onto the depigmented areas. This is best suited for segmental vitiligo or small, stubborn patches that haven’t responded to other treatments.
Linked Autoimmune Conditions
Vitiligo rarely exists in complete isolation. Because it stems from immune system dysfunction, people with vitiligo have a higher rate of other autoimmune conditions. The strongest association is with autoimmune thyroid disorders, particularly Hashimoto’s thyroiditis and Graves’ disease. Other associated conditions include type 1 diabetes, rheumatoid arthritis, alopecia areata (patchy hair loss), and pernicious anemia. Having vitiligo doesn’t mean you’ll develop these conditions, but it does make periodic screening worthwhile.
Living With Vitiligo
Sun protection takes on extra importance with vitiligo. Depigmented skin has no melanin to shield it from UV radiation, making it highly vulnerable to sunburn. Broad-spectrum sunscreen with SPF 30 or higher on exposed patches is essential, both to prevent burns and to reduce the contrast between affected and unaffected skin during summer months.
Cosmetic camouflage products, ranging from everyday concealer to specialized waterproof formulations designed for vitiligo, can be effective for patches on visible areas. Some people also use self-tanning products on white patches, though results vary depending on the product and skin tone.
The psychological weight of vitiligo is well documented and worth acknowledging. Visible skin changes affect self-image, and the unpredictable course of the disease adds its own layer of stress. Support communities, both online and in person, are widely available and can be genuinely helpful for people navigating the emotional side of the condition.